They highlighted a significant association between FLT3 and NPM1 mutations, with FLT3 being nearly four times more prevalent in NPM1mut MDS patients compared to NPM1wt (p < 0.001). This evidence concerns the gene FLT3 and myelodysplastic syndrome.